Delivery Order SPE2DB25D3018-SPE2DB25FUXSU

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price of $1,741.68 and a completion date of September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medical products. The contract has a ceiling value of $10,740.82 and runs through April 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,825.39, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 17, 2025. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,683.69, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of September 19, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, at a ceiling value of $1,024.22. The contract is a firm fixed-price delivery order with a completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,801.34 firm fixed-price contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,734.20 firm fixed price contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication, with a completion date of September 26, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,134.70 firm-fixed-price contract is for the provision of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $9,376.04 and runs through April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,801.80, is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of December 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB25D3018
    Indefinite Delivery Contract
  • SPE2DB25D3018-SPE2DB25FUXSU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The order has a firm fixed price of $6,441.46 and an ultimate completion date of June 13, 2025. The contract is not set aside and was awarded on June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/11/25, 11:01 AM